Dimethyl Fumarate Kit
Product Images NDC 31722-680

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 31722-680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dimethylfumatratestructure (Dimethylfumatratestructure)

Chemical structure of dimethyl fumarate showing the arrangement of carbon, oxygen, and hydrogen atoms with double bonds and ester functional groups as represented in the molecular diagram.*

FDA Label Image

Dimethylfumaratefig1 (Dimethylfumaratefig1)

A line graph comparing the percentage of subjects with confirmed progression of disability over 96 weeks between a placebo group and a group receiving dimethyl fumarate delayed-release capsules 240 mg BID. The vertical axis shows the percentage of subjects, and the horizontal axis shows time on study in weeks. The graph indicates lower progression percentages for the dimethyl fumarate group compared to placebo.*

FDA Label Image

Dimethylfumaratecamberlogo (Dimethylfumaratecamberlogo)

FDA Label Image

Dimethylfumaratestarterpack (Dimethylfumaratestarterpack)

Dimethyl Fumarate Delayed-Release Capsules, USP 30-Day Starter Pack packaging label from Camber Pharmaceuticals, Inc. The label includes instructions for use with a 120 mg starter dose bottle for days 1 to 7 and a 240 mg regular dose bottle for days 8 to 30. It also displays storage instructions, a U.S. contact number, and manufacturing information by Hetero Labs Limited. The pack contains one bottle of 14 capsules (120 mg each) and one bottle of 46 capsules (240 mg each).*

FDA Label Image

Dimethylfumarate120mg14s (Dimethylfumarate120mg14s)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules, USP 120 mg by Camber Pharmaceuticals, Inc. The label shows a 14-capsule quantity, a barcode, storage instructions, and manufacturer details including a contact number. The label also features a pink area marked "43 x 23 mm Un Varnish Area."*

FDA Label Image

Dimethylfumarate120mg14sc (Dimethylfumarate120mg14sc)

Dimethyl Fumarate 120 mg delayed-release capsules packaging label from Camber Pharmaceuticals, Inc. The label indicates 14 capsules per package. It includes instructions to swallow capsules whole, storage temperature guidance, and the U.S. contact number. The label also shows the NDC 31722-657-31, barcode, and manufacturing information by Hetero Labs Limited, India.*

FDA Label Image

Dimethylfumarate240mg60s (Dimethylfumarate240mg60s)

Label for Dimethyl Fumarate Delayed-Release Capsules, USP 240 mg by Camber Pharmaceuticals, Inc. The label indicates a bottle containing 60 capsules, with storage and dosage instructions, a barcode, and manufacturer contact information. The label also includes a designated area for batch coding.*

FDA Label Image

Dimethylfumarate240mg60sc (Dimethylfumarate240mg60sc)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules, USP 240 mg by Camber Pharmaceuticals, Inc. The label states the product is prescription only with 60 capsules per package. It includes directions to swallow whole and store at controlled room temperature. Manufactured for Camber Pharmaceuticals, Piscataway, NJ, with additional manufacturing by Hetero Labs Limited, India.*

FDA Label Image

Dimethylfumarate240mg46s (Dimethylfumarate240mg46s)

Packaging label for Dimethyl Fumarate delayed-release capsules, USP, 240 mg strength. The label indicates the product is manufactured for Camber Pharmaceuticals, Inc. and contains 46 capsules. It includes storage instructions and contact information, with the dosage form and strength prominently displayed.*

FDA Label Image

Dimethylfumarate240mg46sc (Dimethylfumarate240mg46sc)

Packaging label for Dimethyl Fumarate Delayed-Release Capsules, USP 240 mg by Camber Pharmaceuticals, Inc. The label indicates 46 capsules per package with dosage instructions, storage conditions, and manufacturer information. The NDC is 31722-658-31 and the capsules are for oral use with Rx only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.